Results 141 to 150 of about 1,026 (172)
Some of the next articles are maybe not open access.
Canadian Journal of Health Technologies
Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the exception ...
openaire +1 more source
Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class. The assessments inform nonbinding recommendations that help guide the reimbursement decisions of Canada’s federal, provincial, and territorial governments, with the exception ...
openaire +1 more source
Bulevirtide for Chronic Hepatitis D
New England Journal of Medicine, 2023Hua, Fu, Yang, Liu, Qi, Liu
openaire +2 more sources
[Treatment and challenges of bulevirtide in chronic hepatitis D].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023In July of 2020, bulevirtide was conditionally approved for the treatment of adults with compensated chronic hepatitis D. Some clinical studies have evaluated the safety and efficacy of bulevirtide as a treatment option for chronic hepatitis D in recent years. Herein are presented a brief review and an outline.
X B, Lu, X Z, Wang
openaire +1 more source
Bulevirtide for Chronic Hepatitis D. Reply.
The New England journal of medicine, 2023Wedemeyer, Heiner, Lampertico, Pietro
openaire +2 more sources
A 3-Year Course of Bulevirtide Monotherapy May Cure HDV Infection in Patients With Cirrhosis
Journal of Hepatology, 2023Christoph Neumann-Haefelin +2 more
exaly